Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT

Position in AGIO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,967,248
+$297,438 QoQ
Shares Held
58,151
-5.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Mar 31, 2026
CallValue
$463,471
CallShares
13,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $333,367,683 across 117 Biotechnology names. AGIO ranks #29 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGIO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $463,471 13,700
2026-03-31 $1,967,248 58,151
2025-12-31 $318,474 11,700
2025-12-31 $1,669,810 61,345
2024-12-31 $938,251 28,553
2024-03-31 $1,044,862 35,734
2023-12-31 $621,288 27,898
2023-03-31 $338,922 14,755
2022-12-31 $717,865 25,565
2022-09-30 $631,888 22,344
2022-06-30 $503,879 22,728
2022-03-31 $2,309,441 79,335
2021-12-31 $2,754,999 83,815
2021-03-31 $397,111 7,690
2020-12-31 $1,081,820 24,967
2020-09-30 $1,971,830 56,338
2020-06-30 $900,870 16,845